2877: China Shineway Pharmaceutical Group Limited - Summary | Jitta

China Shineway Pharmaceutical Group Limited

HKG:2877

Price
HK$8.47
Loss Chance
42.5%
6.02JITTA SCORE
18.59%Under Jitta Line
Jitta Ranking
31 / 233
214 / 2,518
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (51)
Recent Business Performance (64)
Financial Strength (89)
Return to Shareholders (45)
Competitive Advantage (53)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Operating MarginExpansion
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
CapExVery Low
SG&A to SalesDecreasing Every Year
Revenue and EarningRevenue decline from 2022-2025
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.02
18.59%
4.42
147.70%
3.82
206.24%
Pharmaceuticals
7.55
105.96%
7.84
19.98%
6.59
20.42%
COMPANY DESCRIPTION
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, chronic illnesses, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of Forway Investment Limited.